Enservco Corp (NASDAQ:ENSV) was upgraded by equities researchers at TheStreet from a “hold” rating to a “buy” rating in a research report issued on Friday, AR Network reports. Enservco Corp (NYSEMKT:ENSV) stock performance was 3.72% in last session and finished the day at $2.23. Traded volume was 173.518million shares in the last session and the…
Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day…
PTC Therapeutics, Inc. (NASDAQ:PTCT) announced a corporate update and reported its financial results for the fourth quarter and full-year ended December 31, 2013. In April 2013, PTC Therapeutics, Inc. (NASDAQ:PTCT) initiated the confirmatory Phase 3 ACT DMD (Ataluren Confirmatory Trial in DMD) clinical trial evaluating ataluren as a potential treatment for patients with nonsense mutation…
